Human Insulin Market is expected to generate a revenue of USD 63.64 Billion by 2028, Globally, at 7.65% CAGR: Verified Market Research® – PR Newswire

Searching for your content…
In-Language News
Contact Us
888-776-0942
from 8 AM – 10 PM ET
News provided by
Nov 15, 2022, 11:30 ET
Share this article
In recent years, the reimbursement scenario for human insulin has become much better, thus increasing the procurement of human insulin. Also, the increase in the demand of human insulin has assisted the market to reach its current height.
JERSEY CITY, N.J., Nov. 15, 2022 /PRNewswire/ — Verified Market Research recently published a report, “Human Insulin Market” By Application (Type I Diabetes, Type II Diabetes), By Delivery Device (Syringes, Pens, Pen Needles), By Brand (HI Analogs And Biosimilars, HI Biologics), By Type (Insulin Analogs And Biosimilars, HI Biologics), By Product Type (HI Drugs, HI Delivery Devices), By Geographic Scope And Forecast.

As per the deep research carried out by Verified Market Research, the global Human Insulin Market size was valued at USD 35.95 Billion in 2020 and is projected to reach USD 63.64 Billion by 2028, growing at a CAGR of 7.65% from 2021 to 2028.
Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample/?rid=24234
Browse in-depth TOC on “Human Insulin Market“
202 – Pages
126 – Tables
37 – Figures
Global Human Insulin Market Overview
Insulin is a hormone secreted by the beta cells present in the pancreas. Insulin is the key element in regulating blood sugar. Along with maintaining the blood glucose, Insulin also manages the uptake of amino acids by the body cells. When a person suffers from diabetes, their body fails to absorb the blood sugar from the blood vessels, thus keeping the blood glucose levels high. Not being able to uptake the glucose, that person’s body cells may suffer from lethal conditions such as the nephropathy and diabetic retinopathy. In type 1 diabetes, a person’s body fails to secrete enough amounts of insulin, thus needing to take external insulin.
The prevalence for type 1 diabetes has increased exponentially in recent years. Because of this, the demand for human insulin analogs has also increased. This growth is also being supported by the healthcare sector, making it easier for the diabetic people to procure insulin, as the expenses are assisted by their health insurance. With the introduction of portable insulin injectors such as the insulin pen, the acceptance for the treatment has increased. The growing spending’s in research and development activities is expected to propel the market growth significantly.
Key Players
The major players in the market are B. Braun Melsungen AG, Becton, Dickinson and Company, Biocon Limited, Biodel Inc., ELI Lilly and Company, Julphar (Also Known as Gulf Pharmaceutical Industries), NOVO Nordisk A/S, Sanofi, Wockhardt Limited, Ypsomed AG.
Verified Market Research has segmented the Global Human Insulin Market On the basis of Application, Delivery Device, Brand, Type, Product Type, and Geography.
Browse Related Reports:
Type 2 Diabetes Treatment Market By Drug Class (Insulin, Non-Insulin), By Devices (Insulin Pumps, Insulin Pen, Blood Glucose Meters), By Geography, And Forecast
Continuous Subcutaneous Insulin Infusion Market By Product (Tethered Pumps, Patch Pumps), By Patient (Type 1, Type 2), By End Use (Hospitals, Home care, Laboratories), By Geography, And Forecast
Insulin Pumps Market By Product (Insulin Pump, Accessories), By Competitive Landscape, By Geography, And Forecast
Insulin Storage Devices Market By Product (Insulated Kits, Battery Operated Insulin Storage Devices), By Application (Type 1 Diabetes, Type 2 Diabetes), By Geography, And Forecast
Top 10 Diabetes Care Devices keeping diabetes at bay internationally
Visualize Human Insulin Market using Verified Market Intelligence -:
Verified Market Intelligence is our BI Enabled Platform for narrative storytelling in this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue-impacting decisions for a brilliant future.
VMI provides a holistic overview and global competitive landscape with respect to Region, Country, Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.
About Us
Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SME’s offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.
We study 14+ categories from Semiconductor & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & construction, Agriculture industry and Medical Devices from over 100 countries.
Contact Us
Mr. Edwyne Fernandes
Verified Market Research®
US: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US Toll Free: +1 (800)-782-1768
Email: [email protected]
Web: https://www.verifiedmarketresearch.com/
Follow Us: LinkedIn | Twitter
Logo: https://mma.prnewswire.com/media/1315349/Verified_Market_Research_Logo.jpg
SOURCE Verified Market Research
More news releases in similar topics
Cision Distribution 888-776-0942
from 8 AM – 9 PM ET

source